Hayon Igal Louria

Chief Technology Officer, Raphael Pharmaceutical Inc.

Companies

Raphael Pharmaceutical Inc.Chief Technology Officer Jan 19, 2022 to now¹
Raphael Pharmaceutical Inc.Board member Jan 19, 2022 to Mar 25, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Raphael Pharmaceutical Inc. RAPH1,349,000 shares²$2.0M at $1.51Nov 20, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 20, 2025Exercised 350,000 shares at $0.01 of Raphael Pharmaceutical Inc.²
Aug 29, 2023Exercised 999,000 shares at $0.01 of Raphael Pharmaceutical Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRaphael Pharmaceutical Inc., Chief Technology Officer
2
SEC EDGARRaphael Pharmaceutical Inc. shares after the filing of Nov 20, 2025
3
SEC EDGARForm 4 filed Mar 25, 2024